Literature DB >> 20422745

Time, clinic technologies, and the making of reflexive longevity: the cultural work of time left in an ageing society.

Sharon R Kaufman1.   

Abstract

Developments in clinical intervention are having a profound impact on health and health behaviours in late life and on ideas about longevity and the appropriate time for death. The fact that the timing of death is even considered to be a controllable event is a relatively new cultural phenomenon. The activities that make up life extension, like other medical practices scrutinised by social scientists, constitute a site for the emergence of new forms of subjectivity. For older adults the clinical encounter forces a calculation about how much time left is wanted in relation to age. The twin dimensions of the transformation of time highlighted in this article - the control over the timing of death and the creation of time left - both contribute to and are a widespread effect of biomedicalisation in affluent sectors of society. Through three stories this paper begins to map the cultural work that the concept, time left, does, the socio-medical ways in which that notion is talked about, organised and calculated in the American clinic today. It asks, what kind of subject emerges when longevity, imbued with the technological, becomes a reflexive practice and an object of intervention and apparent choice?

Entities:  

Keywords:  biotechnology; life extension; modernity; old age; subjectivity

Mesh:

Year:  2010        PMID: 20422745      PMCID: PMC2860035     

Source DB:  PubMed          Journal:  Sociol Health Illn        ISSN: 0141-9889


  6 in total

1.  Health as a meaningful social practice.

Authors:  Robert Crawford
Journal:  Health (London)       Date:  2006-10

2.  Clinical life: expectation and the double edge of medical promise.

Authors:  Janet K Shim; Ann J Russ; Sharon R Kaufman
Journal:  Health (London)       Date:  2007-04

3.  Controlling death--compromising life: chronic disease, prognostication, and the new biotechnologies.

Authors:  Ronald J Maynard
Journal:  Med Anthropol Q       Date:  2006-06

Review 4.  Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer.

Authors:  Robin Matsuyama; Sashidhar Reddy; Thomas J Smith
Journal:  J Clin Oncol       Date:  2006-07-20       Impact factor: 44.544

5.  Trends in the aggressiveness of cancer care near the end of life.

Authors:  Craig C Earle; Bridget A Neville; Mary Beth Landrum; John Z Ayanian; Susan D Block; Jane C Weeks
Journal:  J Clin Oncol       Date:  2004-01-15       Impact factor: 44.544

6.  The role of chemotherapy at the end of life: "when is enough, enough?".

Authors:  Sarah Elizabeth Harrington; Thomas J Smith
Journal:  JAMA       Date:  2008-06-11       Impact factor: 56.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.